-
(S)-2-Chloro-N-(6-methyl-5-((3-(2-(piperidin-3-ylamino)pyrimidin-4-yl)pyridin-2-yl)oxy)naphthalen-1-yl)benzenesulfonamide
-
BD4355861630086-20-297%
-
¥1646.050mg
-
2-Hydroxy-6-(5-(4-methylpiperazine-1-carbonyl)thiophen-2-yl)-1-naphthaldehyde
-
BD7634051093119-54-097%
-
¥748.025mg
-
N2-(1H-Benzo[d]imidazol-6-yl)-N4-(5-cyclopropyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine
-
BD6300071216665-49-498%
-
¥1198.050mg
-
N-((2-Hydroxynaphthalen-1-yl)methylene)thiophene-2-sulfonamide
-
BD630628307543-71-198%
-
¥504.0100mg
-
7-Hydroxy-6-methoxy-3-(2-(2-methoxyethoxy)ethyl)-4-methyl-2-oxo-2H-chromene-8-carbaldehyde
-
BD008316401338934-20-598%
-
¥1113.05mg
-
1-(4-(8-Amino-3-(tert-butyl)imidazo[1,5-a]pyrazin-1-yl)naphthalen-1-yl)-3-(3-(trifluoromethyl)phenyl)urea
-
BD5606771589527-65-097%
-
¥926.010mg
-
7-Hydroxy-6-methoxy-4-methyl-3-(2-morpholino-2-oxoethyl)-2-oxo-2H-chromene-8-carbaldehyde
-
BD009610931338934-59-099%
-
¥4194.0100mg
-
7-(1,3-Dioxan-2-yl)-8-hydroxy-1,2,3,4-tetrahydro-5H-chromeno[3,4-c]pyridin-5-one
-
BD011292301607803-67-799+%
-
¥23998.0100mg
-
IRE1α kinase-IN-1
-
BD014720642328097-41-098%
-
¥70148.0100mg
-
IRE1α kinase-IN-3
-
BD015806812416223-41-998%
-
¥
-
IRE1α kinase-IN-5
-
BD023049692771006-47-298%
-
¥
-
(S)-2-(3,4-Dichlorobenzyl)-N-(4-methylbenzyl)-2,7-diazaspiro[4.5]decane-7-carboxamide
-
BD013182372309519-81-998%
-
¥
-
PAIR2
-
BD015899892771006-54-198%
-
¥
-
GSK2850163 hydrochloride
-
BD013015452319838-09-898%
-
¥
-
(R)-2-(3,4-Dichlorobenzyl)-N-(4-methylbenzyl)-2,7-diazaspiro[4.5]decane-7-carboxamide
-
BD011176932121989-91-998%
-
¥13660.0100mg
-
IRE1α kinase-IN-6
-
BD015055192715123-88-798%
-
¥
-
IRE1α kinase-IN-9
-
BD023204791338933-30-498%
-
¥
-
KIRA9
-
BD015105952922507-65-998%
-
¥
-
N-(4-Chlorobenzyl)-N-(2-(indolin-1-yl)-2-oxoethyl)pyridine-3-sulfonamide
-
BD011124721021106-40-097%
-
¥
-
(S)-2-Chloro-N-(6-methyl-5-((3-(2-(piperidin-3-ylamino)pyrimidin-4-yl)pyridin-2-yl)oxy)naphthalen-1-yl)benzenesulfonamide hydrochloride
-
BD011734702250019-92-098%
-
¥2573.05mg